Persona Partial Knee Replacement for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial studies a knee implant called the Persona Partial Knee System in patients needing partial knee replacement. It aims to see how well the implant works and how long it lasts by tracking patients over time. The Persona® system is a newly launched implant designed for knee replacement with innovations intended for better function and higher flexibility.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How is the Persona Partial Knee Replacement treatment different from other treatments for osteoarthritis?
What data supports the effectiveness of the Persona Partial Knee Replacement treatment for osteoarthritis?
Who Is on the Research Team?
Hillary Overholser
Principal Investigator
Zimmer Biomet
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need a knee replacement due to conditions like osteoarthritis or tibial plateau fracture and are suitable for the Persona Partial Knee system. Participants must be able to follow the study plan and give informed consent. Those with severe bone or joint issues, certain neurological disorders, infections, inflammatory diseases, or pregnant women cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Evaluation
Participants undergo preoperative clinical evaluations prior to their partial knee arthroplasty
Treatment
Participants receive the Persona Partial Knee system
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Optional continuation of follow-up assessment up to 10 years
What Are the Treatments Tested in This Trial?
Interventions
- Persona Partial Knee system
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business